Clovis Palmer

In 2011 I was funded by an NIH/IAS to develop metabolic assays to study immune cell dysfunction in HIV+ persons. This research was the first to show dysfunctional immune cell metabolism in persons living with HIV infection. It is the first study to use multi-parametric approaches, combining immune cell markers with metabolic assays to study immune cell metabolic dysfunctions in humans. We are currently developing more immunometabolic techniques to understand HIV pathogenesis.